Mizue N, Watanabe J, Katoh S, Oda T, Suzuki N, Kudoh T
Department of Pediatrics, School of Medicine, Sapporo Medical University.
Rinsho Ketsueki. 1999 Mar;40(3):213-7.
We report our experiences with HLA-matched unrelated bonemarrow transplantation combining a preconditioning regimen of cyclophosphamide, antithymocyte globulin (ATG), and total body irradiation for two patients with severe aplastic anemia (SAA) who had already undergone repeated blood transfusions. Short-term methotrexate and cyclosporine were administered for graft-versus-host disease (GVHD) prophylaxis. Both patients achieved rapid engraftment within 3 weeks, furthermore, neither acute nor chronic GVHD developed. Our conditioning regimen appeared to be well-suited for unrelated bone marrow transplantation in heavily transfused SAA patients. However, both patients experienced bouts of fever about 20-30 and 40-50 days after transplantation, and it was difficult to differentiate whether they were affected by acute GVHD, cytomegalovirus (CMV) infections, or serum sickness. Because weakly positive CMV antigenemia was detected, both patients were given ganciclovir. Although their fever did not respond initially, it gradually subsided following the combined administration of prednisolone. These outcomes suggest it is essential that attention be devoted to the potential for serum sickness and the high risk of herpes virus infections, particularly by CMV, following the use of intensive preconditioning regimens that include ATG.
我们报告了两例严重再生障碍性贫血(SAA)患者在接受 HLA 配型相合的无关供者骨髓移植时的经验,这两名患者均已接受多次输血,预处理方案采用环磷酰胺、抗胸腺细胞球蛋白(ATG)和全身照射。短期给予甲氨蝶呤和环孢素预防移植物抗宿主病(GVHD)。两名患者均在 3 周内迅速植入,此外,均未发生急性或慢性 GVHD。我们的预处理方案似乎非常适合多次输血的 SAA 患者进行无关供者骨髓移植。然而,两名患者在移植后约 20 - 30 天和 40 - 50 天出现发热,很难区分是急性 GVHD、巨细胞病毒(CMV)感染还是血清病所致。由于检测到 CMV 抗原血症弱阳性,两名患者均接受了更昔洛韦治疗。尽管最初发热无反应,但在联合给予泼尼松龙后逐渐消退。这些结果表明,在使用包括 ATG 的强化预处理方案后,必须关注血清病的可能性以及疱疹病毒感染,特别是 CMV 感染的高风险。